This inventor holds 7 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Universitaet Leipzig, Amp-Therapeutics Gmbh. Active years: 2014-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Grosspösna, DE (2015)
- Grossposna, DE (2015)
- Groβpösna, DE (2016 - 2018)
- Grosspoesna, DE (2014 - 2019)
Company Filing History:
Years Active: 2014-2019
Title: Ralf Hoffmann: Innovator in Antibiotic Peptides
Introduction
Ralf Hoffmann is a notable inventor based in Grosspoesna, Germany. He has made significant contributions to the field of antibiotic peptides, holding a total of 7 patents. His work focuses on developing modified peptides that enhance antibiotic activity and broaden the spectrum of effectiveness against various strains of bacteria.
Latest Patents
Hoffmann's latest patents include innovations in modified apidaecin derivatives as antibiotic peptides. This invention pertains to the development of modified antibiotic peptides specifically designed for medical applications. The invention encompasses composites and methods aimed at destroying microorganisms, including bacteria, viruses, and fungi, as well as methods for treating microbial infections. The goal is to create novel antibiotic peptides with enhanced activity, particularly against gram-positive bacteria. Another significant patent involves modified antibiotic peptides that feature variable systemic release. This invention focuses on derivatives of apidaecin and oncocin, which are designed to have increased stability, reduced immunoreaction, and improved pharmacokinetics. The peptide antibiotics are protected by a linker made of polyethylene glycol (PEG), which is cleaved by serum proteases, allowing for the release of the active peptide.
Career Highlights
Throughout his career, Ralf Hoffmann has worked with esteemed institutions such as Universität Leipzig and Amp-Therapeutics GmbH. His research and innovations have contributed to advancements in the medical field, particularly in the development of effective treatments for microbial infections.
Collaborations
Hoffmann has collaborated with notable colleagues, including Daniel Knappe and Kai Hilpert. Their combined expertise has furthered the research and development of antibiotic peptides.
Conclusion
Ralf Hoffmann's contributions to the field of antibiotic peptides demonstrate his commitment to advancing medical science. His innovative patents and collaborations highlight the importance of research in combating microbial infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile